Oncogenic Role of THOR, a Conserved Cancer/Testis Long Non-coding RNA
Yasuyuki Hosono,Yashar S Niknafs,John R Prensner,Matthew K Iyer,Saravana M Dhanasekaran,Rohit Mehra,Sethuramasundaram Pitchiaya,Jean Tien,June Escara-Wilke,Anton Poliakov,Shih-Chun Chu,Sahal Saleh,Keerthana Sankar,Fengyun Su,Shuling Guo,Yuanyuan Qiao,Susan M Freier,Huynh-Hoa Bui,Xuhong Cao,Rohit Malik,Timothy M Johnson,David G Beer,Felix Y Feng,Weibin Zhou,Arul M Chinnaiyan
DOI: https://doi.org/10.1016/j.cell.2017.11.040
IF: 64.5
2017-12-14
Cell
Abstract:Large-scale transcriptome sequencing efforts have vastly expanded the catalog of long non-coding RNAs (lncRNAs) with varying evolutionary conservation, lineage expression, and cancer specificity. Here, we functionally characterize a novel ultraconserved lncRNA, THOR (ENSG00000226856), which exhibits expression exclusively in testis and a broad range of human cancers. THOR knockdown and overexpression in multiple cell lines and animal models alters cell or tumor growth supporting an oncogenic role. We discovered a conserved interaction of THOR with IGF2BP1 and show that THOR contributes to the mRNA stabilization activities of IGF2BP1. Notably, transgenic THOR knockout produced fertilization defects in zebrafish and also conferred a resistance to melanoma onset. Likewise, ectopic expression of human THOR in zebrafish accelerated the onset of melanoma. THOR represents a novel class of functionally important cancer/testis lncRNAs whose structure and function have undergone positive evolutionary selection.